The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study.
- Borgquist, Signe
- Zhou, Wenjing
- Jirström, Karin
- Amini, Rose-Marie
- Sollie, Thomas
- Sørlie, Therese
- Blomqvist, Carl
- Butt, Salma
- Wärnberg, Fredrik
Publication date
January 2015
DOI Publisher
Springer Science and Business Media LLCAbstract
HER2 is a well-established prognostic and predictive factor in invasive breast cancer. The role of HER2 in ductal breast carcinoma in situ (DCIS) is debated and recent data have suggested that HER2 is mainly related to in situ recurrences. Our aim was to study HER2 as a prognostic factor in a large population based cohort of DCIS with long-term follow-up
Add to ORKG